|
|
Volumn 6, Issue 2, 1997, Pages 105-110
|
|
Anticoagulant therapy in patients aged 80 years or more with atrial fibrillation. More caution is needed.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
WARFARIN;
AGE;
AGED;
BLEEDING;
CEREBROVASCULAR DISEASE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
HEART ATRIUM FIBRILLATION;
HUMAN;
MIDDLE AGED;
MORTALITY;
NOTE;
RISK;
AGE FACTORS;
AGED;
AGED, 80 AND OVER;
ANTICOAGULANTS;
ASPIRIN;
ATRIAL FIBRILLATION;
CEREBROVASCULAR DISORDERS;
CLINICAL TRIALS;
HEMORRHAGE;
HUMANS;
MIDDLE AGED;
RISK;
WARFARIN;
|
|
EID: 0031093797
PISSN: 10633987
EISSN: None
Source Type: Journal
DOI: 10.1001/archfami.6.2.105 Document Type: Note |
|
Times cited : (4)
|
|
References (82)
|
